Free Mesothelioma Information Packet

Jack A. Elias M.D.

  • Chair of Pulmonary and Critical Care Medicine
  • Yale Center for Clinical Investigation
  • 203-785-4119

Jack A. Elias received his Medical Degree from the University Of Pennsylvania School Of Medicine. Afterwards Dr. Elias completed two residencies and two fellowships. The first of these residencies was at Tufts-New England Medical Center in Boston, Massachusetts and the second residency was completed at the Hospital of the University of Pennsylvania. Both of his fellowships were completed at the Hospital of the University of Pennsylvania, one focused on Allergy and Immunology and the other focused on Pulmonary and Critical Care medicine. Currently, he is the Waldemar Von Zedtwitz Professor and Chair of Pulmonary and Critical Care Medicine at the Yale Center for Clinical Investigation. Dr. Elias’ career has been marked with many honors and achievements especially the Recognition Award for Scientific Accomplishment from the American Thoracic Society. He has also been consistently funded by the National Institute of Health since 1984 and he is the Principal Investigator on one Program Project grant. He has also been given four RO1 awards and a T32 training grant in Pulmonary Biology. He is considered an expert on lung inflammation, injury, repair, and remodeling responses and has developed murine modeling systems to investigate pathogenic mechanisms that contribute to remodeling responses. He also was the first to translate pathogenic mechanisms in these models to humans and human disorders. He is the mentor of many doctors who have found success after their time with him and he is widely publicized. His most well-known publication is Fishman’s Manual of Pulmonary Diseases and Disorders. Dr. Elias’ clinical interests include asthma, COPD, interstitial lung disease, and acute lung injury. Although he does do some work related to Mesothelioma his main clinical and research interests are geared towards asthma and emphysema. Currently, he is researching the cellular and molecular pathogenesis of asthma and COPD. He is also researching cellular and molecular mechanisms of lung injury, repair and remodeling. He also is clinically researching a transgenic modeling of Pulmonary diseases and disorders, the effector mechanisms of IL-13, VEGF, and TGF-beta type, Th2, and Th1 cytokines in the lung.

References:
  • Yale University Center for Clinical Investigation. Physician Profile.

Last modified: December 24, 2010.